|
Published February 22, 2008 at 12:44 PM
|
We've got healthcare and sovereign wealth on our minds in next week's edition of The Deal. Our cover story by Matt Miller takes a hard look at Temasek Holdings Pte. Ltd., one of two large Singaporean sovereign wealth funds and one of the more transparent SWFs in the world (this is relative: It mostly means Temasek publishes an annual report). Temasek has stirred up opposition in various parts of the world as it's steadily expanded outside the city-state, throughout Asia and now to the West. And that's not only its problem, but that of similar funds out of China or the Gulf Coast: Their very success creates political opposition, much like the backlash on the Dubai ports deal in the U.S. or, this week, to 3Com Corp.'s deal with Bain Capital LLC, which involved a Chinese company with links to the Chinese military. On the healthcare front, Alex Lash takes a look at a handful of private equity shops with different strategies to finance cutting-edge biotech drug development; Cheyl Meyer reports on Inverness Medical Innovations Inc., a deal-intensive diagnostic house that surprised the market with a bad quarter earlier this week; and Bill McConnell ponders the M&A fallout from tightening Medicare reimbursement rates.
Continue reading below
Elsewhere in the issue, we've got fourth-quarter bankruptcy league tables plus a story that reports on the ways bankruptcy reform is shaping the building surge of Chapter 11s. In the columns, Media Maneuvers tackles the reporting on the credit crunch, and Backstory probes the way ahead for Clear Channel Communications Inc. In our due diligence section, Follow the Money follows the crunch into the middle market while Capital Calls looks at how Kohlberg Kravis Roberts & Co. is getting good grades from some credit agencies. We also feature another edition of Pipeline, which focuses on buyout deals for Clear Channel, Hexion Specialty Chemicals Inc., BCE Inc., Goodman Global Holdings Inc. and 3Com. And, of course, there's lots more. - Robert Teitelman See The Deal newsweekly cover story "Temasek rising"
See The Deal newsweekly story on CFIUS and 3Com
See The Deal newsweekly story on private equity and biotech
See The Deal newsweekly story on Medicare, medicaid and M&A
See The Deal newsweekly story on Inverness
See The Deal newsweekly bankruptcy feature
See Media Maneuvers
See Backstory
See Capital Calls
See Follow the money
See Pipeline
|
